Health Reform Plans Offer Difficult Choices For Patients, Researchers, Practitioners
In Brief: William Paul to Head AIDS Research Officer; Schachman Is NIH Extramural Obudsman
NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen
NIH Limits Salaries On Grants, Contracts ACS Clinical Awards Available For 1995
Letters: NCI Mammography Statement Recognizes Patient Autonomy
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









